Search company, investor...

Founded Year



Series C | Alive

Total Raised


Last Raised

$28M | 4 yrs ago

About Arterys

Arterys is a company that focuses on the integration of artificial intelligence and data in the medical sector, specifically in the domain of radiology. The company offers a cloud-based platform that uses AI to extract actionable insights from medical images, aiming to improve diagnostic decision making, efficiency, and productivity. Its services primarily cater to the healthcare industry. Arterys was formerly known as Morpheus Medical, Inc.. It was founded in 2011 and is based in San Francisco, California.

Headquarters Location

51 Federal Street Suite 305

San Francisco, California, 94107,

United States



ESPs containing Arterys

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Healthcare & Life Sciences / Monitoring, Imaging & Diagnostics Tech

The radiology AI — cardiac CT analytics market is focused on improving the diagnosis and management of heart disease through the use of artificial intelligence and advanced imaging technologies. Companies in this market use AI to accurately detect and analyze features such as coronary artery stenosis, ventricular hypertrophy, and other anomalies that can be indicative of cardiac-related diseases. …

Arterys named as Leader among 9 other companies, including Cleerly, HeartFlow, and Shukun Technology.


Expert Collections containing Arterys

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Arterys is included in 5 Expert Collections, including AI 100.


AI 100

199 items

Winners of CB Insights' annual AI 100, a list of the 100 most promising AI startups in the world.


Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare


Artificial Intelligence

10,958 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.


Digital Health 150

300 items

The most promising digital health startups transforming the healthcare industry


Digital Health

10,585 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Arterys Patents

Arterys has filed 29 patents.

The 3 most popular patent topics include:

  • medical imaging
  • magnetic resonance imaging
  • image processing
patents chart

Application Date

Grant Date


Related Topics




Medical imaging, Magnetic resonance imaging, Nuclear magnetic resonance, Neuroimaging, 2d nuclear medical imaging


Application Date


Grant Date



Related Topics

Medical imaging, Magnetic resonance imaging, Nuclear magnetic resonance, Neuroimaging, 2d nuclear medical imaging



Latest Arterys News

Software as a Medical device (SaMD) Market projected to experience a robust CAGR of 51.88%

Sep 19, 2023

News Provided By Share This Article The software as a medical device (SaMD) market is estimated to grow at a CAGR of 51.88% during the forecast period. The software as a medical device (SaMD) market is estimated to grow at a CAGR of 51.88% during the forecast period.” — Knowledge Sourcing Intelligence NOIDA, UTTAR PRADESH, INDIA, September 19, 2023/ / -- According to a new study published by Knowledge Sourcing Intelligence, the software as a medical device (SaMD) market is projected to grow at a CAGR of 51.88% between 2021 and 2028. The prime factor driving the demand for software as a medical device (SaMD) market is the increasing integration of IoT (Internet of Things) technology in the healthcare sector. The surge in demand for digital health solutions, particularly for remote patient monitoring and telehealth services, plays a significant role in this upward trend. Additionally, the growing consumer inclination towards advanced wearables is contributing to the rising adoption of connected healthcare devices, driven by an increase in disposable income among consumers globally. Software as a medical device market, encompasses software designed for medical purposes and functions autonomously without reliance on specific medical hardware. Notably, the COVID-19 pandemic has expedited the adoption of virtual healthcare, fostering an environment favorable for the utilization of SaMD applications. The SaMD industry is experiencing a boom in demand, which is being driven primarily by the growing adoption of the Internet of Things (IoT) and connected healthcare devices. This surge in IoT device adoption is propelled by the global increase in chronic illnesses and an aging population, particularly in remote patient monitoring. Moreover, substantial investments in IoT are catalyzing healthcare innovations, such as AI and big data analytics, further boosting the global SaMD market. Governments worldwide, like the U.S. Department of Health and Human Services (HHS), are actively embracing IoT technology integration in healthcare management, signifying a concerted effort to harness IoT's potential in enhancing healthcare services and operations. In a recent market development, In November 2021, HoneyNaps, a healthcare startup, unveiled "SOMNUM," a medical software that leverages artificial intelligence algorithms to diagnose, predict, and prevent diseases by analyzing data from Polysomnography. Furthermore, Supportive government policies that promote business activities are also playing a significant role in driving the growth of the SaMD market. For instance, in November 2021, the FDA released a new set of guidelines outlining key considerations for assessing the safety and efficacy of device software. Access sample report or view details: Based on device type, the Software as a Medical Device market is segmented into PCs and Laptops, Smartphones/tablets, and wearable devices. The PC/laptop category held a strong market position due to its extensive use in applications. Personal computers (PCs) and laptops within the SaMD market empower healthcare providers to deliver medical services to patients residing in remote or underserved regions. Based on deployment, the SaMD market is divided into cloud and on-premise. The cloud segment held the largest share of revenue. Cloud computing is a service that provides various infrastructure services like networking, storage, software, and databases through subscription-based models. The healthcare industry, particularly the medical devices sector, has rapidly embraced cloud computing technology. Based on applications, the software as a medical device market is categorized into diagnostics and clinical management. The diagnostics segment holds a substantial share. This diagnostic tool furnishes medical professionals with crucial insights into a patient's health status, enabling them to monitor health data and modify treatments as needed. Based on geography, the market has been segmented into the Americas, Europe, the Middle East and Africa, and the Asia Pacific. The Americas, particularly the United States, held a significant portion of the software as a medical device (SaMD) market. The increased integration of advanced technologies into the medical and healthcare field for enhanced diagnosis and treatment is driving the demand for software as a medical device (SaMD) in the United States. As a part of the report, the major players operating in the Software as a medical device market, that have been covered are Arterys Inc, Qlarity Imaging LLC, Viz.AI, Inc, Imagen Technologies, Apple Inc, Ischemaview Inc, Digital Diagnostics Inc, MaxQ AI, Ltd, Greenfinch Technology, Siemens Healthineers AG, and Koninklijke Philips N.V. among others. The market analytics study segments the Software as a medical device (SaMD) market on the following basis: • By Device Type

Arterys Frequently Asked Questions (FAQ)

  • When was Arterys founded?

    Arterys was founded in 2011.

  • Where is Arterys's headquarters?

    Arterys's headquarters is located at 51 Federal Street, San Francisco.

  • What is Arterys's latest funding round?

    Arterys's latest funding round is Series C.

  • How much did Arterys raise?

    Arterys raised a total of $70M.

  • Who are the investors of Arterys?

    Investors of Arterys include Emergent Medical Partners, Temasek, Varian Medical Systems, Fosun Capital, Revelation Partners and 14 more.

  • Who are Arterys's competitors?

    Competitors of Arterys include, Kheiron Medical Technologies, deepc,, Koios Medical and 7 more.


Compare Arterys to Competitors

Aidoc Logo

Aidoc operates as a healthcare technology company providing a care coordination platform. It offers a wide range of solutions such as real-time notifications for neuro care, automatic analysis of imaging to identify abnormalities, and more. It was founded in 2016 and is based in Tel Aviv, Israel.

Enlitic Logo

Enlitic is a company that focuses on healthcare data management, specifically within the domain of radiology. The company offers solutions that standardize, protect, integrate, and analyze medical imaging data, using artificial intelligence to improve clinical workflows and create a real-world evidence medical image database. Enlitic primarily serves the healthcare industry, with a particular focus on radiologists, PACS administrators, hospital executives, and researchers. It was founded in 2014 and is based in San Francisco, California.

Kheiron Medical Technologies

Kheiron Medical Technologies operates as a healthcare software company. It helps cancer patients by analyzing medical images and helps to enable the automation of radiology reporting tasks. It was formerly known as Maesterai. The company was founded in 2016 and is based in London, United Kingdom. Logo provides an artificial intelligence (AI) based system to identify abnormalities in head computed tomography (CT) scans. It leverages deep learning to diagnose diseases from radiology and pathology imaging and create personalized cancer treatment plans from psychopathology imaging and genome sequences. The company was founded in 2016 and is based in Mumbai, India.

Ultromics Logo

Ultromics provides autonomous echocardiography analysis through artificial intelligence (AI) solutions, empowering physicians to make decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing reports for clinicians without any need for physical software on-site. The company was founded in 2017 and is based in Oxford, United Kingdom.

mediaire Logo

mediaire provides medical imaging and magnetic resonance imaging (MRI) assessment software. It is used to improve the workflow of radiologists via quantitative image analysis. It delivers examination results and diagnostic suggestions by retrieving the results from patient reports in a short duration. It was founded in 2018 and is based in Berlin, Germany.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.